iDOVE: Durability of Vaccine Efficacy Against SARS-CoV-2 Infection

Implements a nonparametric maximum likelihood method for assessing potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection under staggered enrollment and time-varying community transmission, allowing crossover of placebo volunteers to the vaccine arm. Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021) <doi:10.1093/cid/ciab630>.

Package details

AuthorYu Gu [aut], Shannon T. Holloway [aut, cre], Dan-Yu Lin [aut]
MaintainerShannon T. Holloway <>
Package repositoryView on CRAN
Installation Install the latest version of this package by entering the following in R:

Try the iDOVE package in your browser

Any scripts or data that you put into this service are public.

iDOVE documentation built on Sept. 15, 2021, 9:08 a.m.